Data / Form D filings / Radiant Biotherapeutics Inc.
Radiant Biotherapeutics Inc.: Form D filing
Radiant Biotherapeutics Inc., a biotechnology company in Montreal Qc, Canada (Federal Level), filed a Form D with the SEC in 2024. The latest, on October 1, 2024, reports $34.3 million sold of a $34.3 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3, Place Ville-Marie, Suite 12350, Montreal Qc, Canada (Federal Level), H2B 0
- Phone
- (514) 298-4222
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Quebec, Canada
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2038848
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | New notice | $34,299,986 | $34,299,986 | 7 | Aug 27, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Arthur Fratamico | Executive Officer, Promoter |
Every Form D from the week of Sep 30, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Radiant Biotherapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.